OpenVSafe by OpenVAERS
Search V-safe

A6R-18023-90853

2 vaccinations 2 coded responses 4 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
380 / TN
Registered
2021-03-30
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-15
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-30
    Registered in v-safe
  3. 2021-03-30
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Heart rate increased — Feeling: Good · Be unable to do your normal daily activities
    Free text: I had increased heart rate up to 145 bpm for more than 2 hours on 03/30/2021. New problem and I have never had this type of sustained elevated heart rate. Felt fatigue after the 1st hour and apple watch notification of HR more than 110 for sometime.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-04-05
    Dose 2 — Pfizer-BioNTech
  5. 2021-04-12
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-04-19
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  7. 2021-07-05
    Survey response — 3 months, dose 2
    MedDRA: Dizziness, Dizziness exertional, Heart rate increased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: On 6/23 Episodic tachycardia with sustained heart rate between 140-155 ish. Self-limiting with dissipation after about 3.5 hours. Dizziness experienced upon movement or ambulation. No difficulty breathing but felt lightheaded when changing position.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-15Pfizer-BioNTech
22021-04-05Pfizer-BioNTech

Free text

Release 6 — day 14, dose 1

2021-03-30

Symptoms: I had increased heart rate up to 145 bpm for more than 2 hours on 03/30/2021. New problem and I have never had this type of sustained elevated heart rate. Felt fatigue after the 1st hour and apple watch notification of HR more than 110 for sometime. cut off by CDC

Release 9 — 3 months, dose 2

2021-07-05

Symptoms: On 6/23 Episodic tachycardia with sustained heart rate between 140-155 ish. Self-limiting with dissipation after about 3.5 hours. Dizziness experienced upon movement or ambulation. No difficulty breathing but felt lightheaded when changing position. cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDDizziness ✓ ✓ ✓
SDDizziness exertional ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release